4-CMTB

CAS No. 300851-67-6

4-CMTB( —— )

Catalog No. M22376 CAS No. 300851-67-6

4-CMTB is a selective agonist of FFA2 and GPR43.It also is a positive allosteric modulator (pEC50=6.38).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 53 In Stock
5MG 79 In Stock
10MG 126 In Stock
25MG 219 In Stock
50MG 323 In Stock
100MG 480 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-CMTB
  • Note
    Research use only, not for human use.
  • Brief Description
    4-CMTB is a selective agonist of FFA2 and GPR43.It also is a positive allosteric modulator (pEC50=6.38).
  • Description
    4-CMTB is a selective agonist of FFA2 and GPR43.It also is a positive allosteric modulator (pEC50=6.38).
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    free fatty acid receptor 2 (FFA2/GPR43)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    300851-67-6
  • Formula Weight
    294.8
  • Molecular Formula
    C14H15ClN2OS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (339.21 mM; Need ultrasonic)
  • SMILES
    CC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Milligan G, Stoddart LA, Smith NJ. Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3. Br J Pharmacol. 2009;158(1):146-153.
molnova catalog
related products
  • Anthralin

    Dithranol is highly effective in the treatment of psoriasis.

  • Odoriflavene

    Odoriflavene has antioxidant activity, and it also shows inhibition effects on the decrease of glutathione level of rat lens induced by UV irradiation.

  • Lupeol acetate

    Lupeol acetate possesses antinociceptive, antifertility, and anti-inflammatory properties, the effect probably involves the opioid system, as indicated by the complete blockade of the opioid antagonist naloxone.